and tumours in other extraskeletal sites (Andreev et al., 1964; Dorney, 1967; Nishiyama et al., 1972; EshunWilson, 1973; Balogh et al., 1985; Berendt et al., 1985). The origin and nature of these cells and their relationship to osteoclasts and macrophage polykaryons is unknown. They are present in the tumour stroma and are generally thought to represent part of the host reponse to the tumour rather than a type of tumour cell. However, their precise function and pathological significance is yet to be determined.
Osteoclast-like multinucleated giant cells are rarely found in otherwise typical infiltrating breast cancers (Fry, 1927; Agnantis & Rosen, 1978; Factor et al., 1977; Holland & van Haelst, 1984; Nielsen & Kiaer, 1985; Tavassoli & Norris, 1986) and tumours in other extraskeletal sites (Andreev et al., 1964; Dorney, 1967; Nishiyama et al., 1972; EshunWilson, 1973; Balogh et al., 1985; Berendt et al., 1985) . The origin and nature of these cells and their relationship to osteoclasts and macrophage polykaryons is unknown. They are present in the tumour stroma and are generally thought to represent part of the host reponse to the tumour rather than a type of tumour cell. However, their precise function and pathological significance is yet to be determined.
In this study, we have examined the ultrastructure and antigenic phenotype of osteoclast-like stromal multinucleate giant cells (OMGCs) in a case of breast carcinoma. We have employed a wide range of monoclonal antibodies of defined specificity in order to clarify the relationship between OMGCs, tumour cells, the osteoclast and other cells of the mononuclear phagocyte system. In addition, we have functionally assessed whether OMGCs behaved like osteoclasts by observing their response to calcitonin and their ability to resorb bone in the presence and absence of known hormonal factors influencing bone resorption. Our findings have implications for macrophage biology and tumour associated osteolysis.
Materials and methods
Bovine parathyroid hormone (PTH) (2,500 U mg-1) was provided by Dr J. Zanelli (National Institute for Biological Standards, London, UK) and dissolved (230 IU ml-1) in 1 ml 0.001 % acetic acid in distilled water containing 1 mg ml-I of bovine serum albumin (Sigma, UK) (BSA). Salmon calcitonin (CT) was donated by Armour Pharmaceuticals, East- bourne, UK (4,450 IU.mg-1) and dissolved (I mgml-1) in 0.05% NaCl and 0.2% sodium acetate in distilled water containing 1 mgml-1 of BSA. Prostaglandin E2(Sigma) (PGE2) was dissolved (10-2 M) in alcohol. 1,25-Dihydroxy vitamin D3 (1,25-(OH)2D3) was donated by Roche products Correspondence: N.A. Athanasou. Received 15 July 1988, and in revised form, 2 November 1988.
(Welwyn Garden City, UK) and dissolved in alcohol. Tissue culture medium used throughout was Eagles Minimal Essential Medium (Flow, UK), supplemented with benzyl penicillin 100 IU ml-1 (Glaxo, UK) and streptomycin 100 pg ml-1 (Glaxo) (MEM); this was used alone for cell isolation and supplemented with 10% heat inactivated FCS (Gibco, UK) (MEM/FCS) for subsequent incubations.
Blocks of cortical bone were obtained at necropsy from the femoral midshaft of patients who had died without evidence of bone disease. These were cleaned of adherent soft tissues then cut longitudinally into bone slices (5 x 3 x 0.3 mm approx) with a low-speed bone saw using a diamond wheel (Buehler Isomet, IL). The bone slices were ultrasonicated for 15min in sterile distilled water, washed in acetone and ethanol then stored dry at room temperature.
Anorganic bone slices were prepared by placing bone slices in 5 ml of hot (55°C) 1,2 ethanediamine (Hydrazine) (Eastman, UK). The solution was changed after one hour and the bone slices then kept in hot hydrazine overnight (Termine et al., 1973) . The bone slices were washed several times in alcohol then left overnight in alcohol. They were then washed in distilled water, dried and transferred to a sterile petri dish and kept at room temperature until used. Table I . Immunohistochemistry was performed by immunoperoxidase or alkaline phosphatase anti-alkaline phosphatase (APAAP) procedures as previously described (Gatter et al., 1984) . Cryostat sections were also stained for tartrate-resistant acid phosphatase using the method described by Evans et al. (1979) . Tissue for transmission electron microscopy was fixed in 4% glutaraldehyde for 6 h, dehydrated in graded alcohols then embedded in epoxy resin (EMix). Thin sections were stained with uranyl acetate and lead citrate and examined in a Jeol 100 CX electron microscope.
Preparation of isolated giant cells
The remainder of the tumour was placed in MEM and utilised immediately for tissue culture. The tumour was divided into equal portions and placed in a 35mm tissue culture dish (Sterilin) containing 2 ml of MEM/FCS. The tumour was finely curetted using a scalpel blade and the fragments vigorously agitated using a smooth-ended glass pipette. Larger fragments were allowed to sediment for one minute and 1 ml of the suspension then added to the various tissue culture dishes as detailed below. Phase contrast examination of these suspensions revealed large numbers of multinucleated cells interspersed amongst abundant mononuclear cells.
Response to calcitonin Following curettage, the tumour cell suspension was added to the wells of a 16mm diameter Costar plate containing a 15mm glass coverslip; these were incubated for 20min at 37°C in 5% CO2. The coverslips were then removed from these wells and washed vigorously to remove non-adherent cells. One of a pair of coverslips was then placed in a well containing CT (1 ng ml -1), the other in control tissue culture medium. The cells were then incubated for 5min, 10min, 30 min, 1 h and 2 h before formalin fixation for staining (Giemsa) . The effectiveness of the CT used in this experiment to inhibit osteoclast motility and induce the characteristic change in osteoclast morphology was confirmed by adding the same CT solution to neonatal rodent osteoclasts which had been isolated in a similar manner as previously described (Chambers & Magnus, 1982) .
Incubation of giant cells on bone slices Following curettage, the tumour cell suspension was added to the wells (16mm diameter) of a tissue culture plate (Costar, UK) containing four or five bone slices (see below) or 15 mm glass coverslips. The cell suspension was incubated on these for 20 min at 37°C, then the bone slices and the coverslips were removed, washed vigorously in MEM and placed in fresh 16 mm diameter wells. For the bone slices, these contained PTH (1 IU m-1), PGE2 (10-5 M), CT (1 nhml-1), 1.25 (OH)2 D3 (10-8 M) or appropriate vehicle controls in 1 ml of MEM/FCS. These were incubated for periods of 24 h, 3 days and 7 days. The 24 h and 3 day cultures contained five bone slices, including one anorganic bone slice; 7 day cultures contained four bone slices. Three bone slices, including one anorganic bone slice derived from 24 h and 3 day cultures and two bone slices from the 7 day cultures, were fixed in 4% glutaraldehyde in 0.2 M cacodylate buffer for 2 h. Two bone slices were placed in Triton X-100 (0.1% in distilled water) for 6 h before glutaraldehyde fixation. Triton treatment removes the cells from the bone surface and enables the underlying substrate to be examined and the number of resorption pits to be accurately counted. The specimens were dehydrated through a graded ethanol series and critical point dried from CO2.
Specimens were coated with gold and examined in a Philips SEM 505 scanning electron microscope. The number of giant cells on the bone slices and the number of resorption pits on the corresponding Triton-treated bone slices which had shared the same well were counted in cultures incubated for 24 h and 3 days. The surface area of each resorption pit was calculated by tracing the outline of the pit on to a digitising tablet linked to a Kontron MOP AMO3 image analyser.
The coverslips, which contained curetted cells from the tumour, were also incubated in MEM/FCS for 24h, 3 days and 7 days in order to assess survival of the giant cells during incubation and, after fixation in cold acetone, to examine the nature of the cells present on the coverslips by immunohistochemistry with monoclonal antibodies PD7/26, EBM/ll and CAM 5.2.
Results
Cytopathology/histopathology The appearance of the cytological smears showed clusters of carcinoma cells and numerous dissociated malignant cells with cytological features similar to the cells in the clumps. In addition, a number of multinucleated cells and occasional morphologically similar mononuclear cells were also present singly and associated with the tumour cell clumps (Figure 1 ). The giant cells had large nuclei with prominent nucleoli and a rather basophilic cytoplasm compared to the surrounding tumour cells. The tumour cells were present in large numbers and were hyperchromatic with anisokaryosis and increased nuclear cytoplasmic ratio.
Grossly, the tumour was a brown 2 cm diameter wellcircumscribed tumour which did not extend to the margins (Figure 3a ) but positive for leucocyte common antigen (LCA) (Figure 3b ). OMGCs also stained with numerous other monoclonal antibodies which react with osteoclasts and cells of the mononuclear phagocyte system, including anti-CD13 antibodies and several antibodies which react with macrophages in a wide variety of tissues, including EBM/l1 (Kelly et al., 1988) and Y-1/82a (Hogg & Horton, 1987) (Figure 3c ). All of these antibodies also strongly Figure 2 Representative field of the tumour showing well differentiated tumour cells islands and ducts with numerous associated OMGCs, some of which are arrowed (Haematoxylin and Eosin x 120). Ultrastructural findings The giant cells had multiple nuclei with irregular outlines. The nucleoplasm contained small amounts of peripherally located dense heterochromatin plus large nucleoli ( Figure  4a ). The cytoplasm contained large amounts of rough endoplasmic reticulin (rER). Both long and short strands of rER were observed. Some of the short strands appeared dilated and contained flocculent material (Figure 4b ). Numerous Figure 6a and b); this closely resembled that previously described for osteoclasts . They had many fine microvilli on their free (upper) surface; these were usually concentrated over the central area of the cell which was often raised into a dome. OMGCs had lobuLdltcd and folded pseudopods over at least part of their periphery, the cell margin at other points having fine filopodia or retraction fibres. (Figure 6a and b) . OMGCs produced resorption cavities of circular or serpiginous outlines and compound excavations which were combinations of the above types. In addition, poorly defined areas of discernible but unmeasurable roughening of the bone surface were also seen particularly around defined resorption pits.
OMGCs were occasionally associated with more than one resorption pit separated by an intervening tract of undisturbed bone (Figure 6a ). Using two sets of paired bone slices, one of which was Triton-treated to remove the cells covering the bone surface, it was possible to determine changes in OMGC numbers and resorption cavity formation over time (Table II) . Clearly, only a small minority of OMGCs were involved in bone resorption in control and hormone-treated cultures. The number of resorption pits did increase with the duration of incubation of cell cultures, indicating that OMGCs were capable of resorbing bone even after a prolonged period of incubation; this was also suggested by the occasional observation of OMGCs partially overlying a resorption pit in 3 day and 7 day cultures.
Bone resorption by OMGCs was seen in both control and hormone-treated cultures. CT had no effect on bone resorption by OMGCs; this was confirmed by measuring the number and area of these pits which did not differ significantly from control values. PGE2 and 1,25-(OH2) vit D3, known stimulators of bone resorption in vivo, also did not greatly influence the number or area of resorption pits produced by OMGCs. However, administration of PTH to
OMGCs cultured on bone greatly increased the number of resorption pits (up to 20-fold). This effect was due to the hormone and not to differences in OMGC number seeded on the bones. The difference between PTH-treated and control or other hormone treated cultures was less marked at 
Discussion
The superficial histological resemblance between osteoclasts and stromal giant cells found in several tumours in a number of extraskeletal sites has led to these giant cells being termed osteoclast-like. In this study, we have shown that a notable additional property which OMGCs isolated from a breast cancer share with osteoclasts is the ability to resorb bone; indeed, to our knowledge, this is the first direct demonstration of bone resorption by a cell type which has not been isolated from bone. In terms of morphological configuration and area, the well-defined areas of bone resorption described in association with OMGCs closely resemble those produced by osteoclasts . The ability of OMGCs to resorb anorganic bone and the occasional observation of isolated OMGCs in close association with a resorption pit also suggests that OMGCs, like osteoclasts, are capable of resorbing all the components of bone. However, bone resorption by OMGCs significantly differs from that of isolated osteoclasts in that it is directly stimulated by PTH and not inhibited by calcitonin McSheehy & Chambers, 1986a,b) . PTH stimulation of osteoclastic bone resorption has only previously been seen when osteoclasts are incubated in the presence of osteoblasts, and osteoclastic bone resorption is also directly inhibited by calcitonin, a feature which is reflected by the characteristic change in the shape of the cell (Chambers & Magnus, 1982) . This morphological response to calcitonin was not exhibited by OMGCs isolated in shortterm cultures on coverslips. Investigation of the antigenic phenotype of OMGCs also showed some similarities and differences between OMGCs and osteoclasts. OMGCs contained several antigenic determinants known to be present on osteoclasts including LCA (Athanasou et al., 1987; Brecher et al., 1986) , CD13 and other macrophage-associated antigens (Athanasou et al., 1988a) , and platelet antigens glycoprotein lIla and CD9 (Athanasou et al., 1988b) . However, OMGCs, unlike osteoclasts, were positive for HLA-DR, and Fc receptors as well as CD14, CD16, CD18 and CDl1c (pl50, 95) antigens. All the above antigens are also expressed by mononuclear phagocytes (Hogg & Horton, 1987) (Andersson et al., 1986) . The absence of reaction for epithelial membrane antigen and cytokeratin staining is further proof that the OMGCs are unlike the epithelial tumour cells themselves.
Although osteoclasts and OMGCs were morphologically and functionally indistinguishable by scanning electron microscopy, OMGCs on transmission EM did not possess a complex ruffled border with a surrounding clear zone, the characteristic ultrastructural feature of the osteoclast (Gothlin & Ericsson, 1976) . In addition, the numerous polyribosomes and cisternae of rER and the fine filament bundles present in the sub-plasmalemmal zone are not characteristic of osteoclasts and are more in keeping with the ultrastructure of a macrophage polykaryon (Papadimitriou & Walters, 1979) .
The above findings suggest that OMGCs are a specific type of macrophage polykaryon which is distinct from both osteoclasts and other types of inflammatory polykaryons such as foreign-body giant cells. Unlike other macrophage polykaryons or macrophages themselves (Chambers & Horton, 1984) , OMGCs can resorb bone in a similar manner to osteoclasts. Osteoclasts, like macrophage polykaryons (Sutton & Weiss, 1966; Chambers, 1978) are formed by the fusion of mononuclear precursors of bone marrow origin (Marks, 1983; Chambers, 1985) and there is now considerable evidence to suggest that these mononuclear precursors and osteoclasts themselves form part of the heterogeneous population of cells in the mononuclear phagocyte system (Mundy & Roodman, 1987) . Accordingly, the cellular and functional differences noted between OMGCs, osteoclasts and macrophage polykaryons could be accounted for by the concept of macrophage heterogeneity (Hopper et al., 1979) . Moreover, the fact that OMGCs isolated from the breast are capable of resorbing bone indicates that a cell of the mononuclear phagocyte system, when transplanted to a different tissue, is capable of performing a highly specialised function of a cell of the mononuclear phagocyte system appropriate to that new tissue location. This suggests that the origin and diversity of macrophage heterogeneity may be determined by the particular local factors and tissue location in which macrophages find themselves (Metcalf, 1984) .
In vitro transformation of peripheral blood monocytes to multinucleated giant cells is greatly increased in breast cancer patients (Al Sumidiae, 1986) and in healthy women with a strong family history of breast cancer .
It has been suggested that this type of giant cell formation is induced by a virus present in monocytes of breast cancer patients, and a retrovirus-like particle has recently been observed ultrastructurally in monocytes and cultured giant cells from patients with breast cancer (Al Sumidiae et al., 1988) . It is possible that a viral gene may also be present in that subpopulation of mononuclear phagocytes which form OMGCs in breast cancer with numerous OMGCs. Viral genes could account for the distinct functional and antigenic differences of these cells from tissue macrophages, inflammatory polykarya and osteoclasts. However, it should be noted that we did not observe virus-like particles in stromal mononuclear cells or OMGCs such as those reported above. Nor have they been reported in any of the many previous ultrastructural studies of breast carcinoma with OMGCs (Factor et al., 1977; Agnantis & Rosen, 1978; Rosen, 1979; Holland & van Haelst, 1983; Sugano et al., 1983; Nielsen & Kiaer, 1985; Tavassoli & Norris, 1986; McMahon et al., 1986; Gupta et al., 1987) .
The existence of an osteoclast-like cell which is directly stimulated by PTH to resorb bone may provide a clue to the cellular and molecular mechanisms of osteolysis associated with malignant tumours. Osteoclasts are generally regarded as the principal cell responsible for bone destruction in solid tumours both in the presence and absence of metastases in bone. No direct evidence of osteolysis by tumour cells has been presented to date (Chambers, 1985) . Our observation of PTH stimulation of bone resorption by cells isolated from a breast carcinoma supports the belief that PTH or a PTH-like protein is important in the humoral hypercalcaemia of malignancy (Mundy et al., 1984; Suva et al., 1987) . It also suggests a possible mechanism whereby solid tumours, such as breast cancer, with bone metastases can effect bone resorption. One of the known effects of PTH is to increase the number of osteoclasts formed from pre-existing precursors (Wong, 1986) . Production of a PTH-like protein by breast cancer cells may be responsible for the accumulation of OMGCs in the unusual primary breast cancer studied. These OMGCs, although capable of bone resorption, have no substrate to resorb in the breast. However, in the more common situation of metastatic breast cancer in bone, secretion of a PTH-like protein by cancer cells in bone would lead to a similar accumulation of OMGCs and these would then resorb the bony substrate in the vicinity of the metastatic tumour cells.
The normal plasma levels of calcium and phosphate seen in the case described are consistent with this concept. In addition, the finding of smaller, possibly mononuclear, cells in association with resorption pits suggests that mononuclear phagocytes, which are commonly found in the inflammatory infiltrate around malignant tumours, may be similarly stimulated and capable of bone resorption.
